Virological Factors Involved in AECHB

  • Hong Tang
  • Mei-Fang Han
  • Ji-Ming Zhang


This chapter describes the features of HBV replication in AECHB, correlation of HBV genotypes, recombination, quasispecies, mutations, viral proteins, gene regulation post gene transcription and viral replication and their contribution to AECHB and HBV ACLF.
  1. 1.

    HBV belongs to the hepadnaviridae family. The HBV virion genome consists of an incomplete annular double-stranded DNA molecule approximately 3.2 kb in size. HBV has four overlapping open reading frames (ORFs), which encode the S, C, X and Polymerase (P) genes.

  2. 2.

    Upon entry into the nucleus of host cells, HBV DNA forms a covalently closed circular form called cccDNA. The (−) strand of cccDNA is the template for transcription of mRNAs of different length. The 3.5 kb mRNA is called pregenome; shorter, subgenomic transcripts are translated into virus proteins. cccDNA is stable in the nucleus and all current antiviral drugs that inhibit viral polymerase are unable to clear the cccDNA, explaining why chronic hepatitis B rebounds frequently.

  3. 3.

    The receptor-binding region of pre-S1 has been reported to interact specifically with sodium taurocholate cotransporting polypeptide (NTCP), a multiple transmembrane transporter predominantly expressed in the liver and shown to be a functional receptor for HBV.

  4. 4.

    Diversification of HBV strains has produced eight genotypes, A–H, which differ in more than 8% of the complete genome, as well as different subgenotypes, which differ by 4–8%. HBV polymerase lacks proofreading function, thus misincorporation of nucleotide mutations occurs during viral replication. HBV genotype B and the G1896A mutation in the preC gene may be associated with the development of acute-on-chronic liver failure.

  5. 5.

    HBx can activate many host genes, including those encoding hfgl2, IL-2, MIG and IP-10, all of which are inflammatory and chemotactic factors involved in the progression of AECHB. The HBc- and HBs-related YMDD mutation can activate the hfgl2 gene, a mechanism resulting in AECHB.

  6. 6.

    HBV transcription is regulated by many transcription factors, including liver-enriched transcription factors, other normal transcription factors (e.g. HNF4, PPARα, HNF3 and HNF1) and HBx protein. Changes in host transcriptional factors may lead to changes in HBV replication, which may result in AECHB.



  1. 1.
    Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev. 2000;64(1):51–68.CrossRefGoogle Scholar
  2. 2.
    Echevarria JM, Avellon A. Hepatitis B virus genetic diversity. J Med Virol. 2006;78(Suppl 1):S36–42.CrossRefGoogle Scholar
  3. 3.
    Glebe D. Recent advances in hepatitis B virus research: a German point of view. World J Gastroenterol. 2007;13(1):8–13.CrossRefGoogle Scholar
  4. 4.
    Gerber MA, et al. Electron microscopy and immunoelectron microscopy of cytoplasmic hepatitis B antigen in hepatocytes. Am J Pathol. 1974;75(3):489–502.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Thomas HC, Lok A, Locarnini S, Zuckerman A. Viral hepatitis. 4th ed. Chichester: Wiley Blackwell; 2014.Google Scholar
  6. 6.
    Gavilanes F, Gonzalez-Ros JM, Peterson DL. Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral proteins. J Biol Chem. 1982;257(13):7770–7.PubMedGoogle Scholar
  7. 7.
    Fung SK, Lok AS. Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology. 2004;40(4):790–2.CrossRefGoogle Scholar
  8. 8.
    Liaw YF, Brunetto MR, Hadziyannis S. The natural history of chronic HBV infection and geographical differences. Antivir Ther. 2010;15(Suppl 3):25–33.CrossRefGoogle Scholar
  9. 9.
    Nassal M. Hepatitis B virus replication: novel roles for virus-host interactions. Intervirology. 1999;42(2–3):100–16.CrossRefGoogle Scholar
  10. 10.
    Seeger C, Zoulim F, Mason W. Hepadnaviridae. In: Knipe DM, Roizman B, Howley PM, et al., editors. Fields virology. 5th ed. Philadelphia, PA: Lippincott Raven Publishers; 2007.Google Scholar
  11. 11.
    Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology. 2003;38(5):1075–86.CrossRefGoogle Scholar
  12. 12.
    Visvanathan K, et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology. 2007;45(1):102–10.CrossRefGoogle Scholar
  13. 13.
    Yan H, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife. 2012;1:e00049.CrossRefGoogle Scholar
  14. 14.
    Gripon P, Cannie I, Urban S. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J Virol. 2005;79(3):1613–22.CrossRefGoogle Scholar
  15. 15.
    Engelke M, et al. Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology. 2006;43(4):750–60.CrossRefGoogle Scholar
  16. 16.
    Meier A, et al. Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes. Hepatology. 2013;58(1):31–42.CrossRefGoogle Scholar
  17. 17.
    Tuttleman JS, Pourcel C, Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell. 1986;47(3):451–60.CrossRefGoogle Scholar
  18. 18.
    Zhu Y, et al. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol. 2001;75(1):311–22.CrossRefGoogle Scholar
  19. 19.
    Bock CT, et al. Structural organization of the hepatitis B virus minichromosome. J Mol Biol. 2001;307(1):183–96.CrossRefGoogle Scholar
  20. 20.
    Wu TT, et al. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology. 1990;175(1):255–61.CrossRefGoogle Scholar
  21. 21.
    Kann M, Gerlich WH. Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus. J Virol. 1994;68(12):7993–8000.PubMedPubMedCentralGoogle Scholar
  22. 22.
    Kann M, Schmitz A, Rabe B. Intracellular transport of hepatitis B virus. World J Gastroenterol. 2007;13(1):39–47.CrossRefGoogle Scholar
  23. 23.
    Kann M, et al. Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex. J Cell Biol. 1999;145(1):45–55.CrossRefGoogle Scholar
  24. 24.
    Porterfield JZ, et al. Full-length hepatitis B virus core protein packages viral and heterologous RNA with similarly high levels of cooperativity. J Virol. 2010;84(14):7174–84.CrossRefGoogle Scholar
  25. 25.
    Bottcher B, Wynne SA, Crowther RA. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature. 1997;386(6620):88–91.CrossRefGoogle Scholar
  26. 26.
    Milich DR, McLachlan A. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science. 1986;234(4782):1398–401.CrossRefGoogle Scholar
  27. 27.
    Milich DR, et al. Comparative immunogenicity of hepatitis B virus core and E antigens. J Immunol. 1988;141(10):3617–24.PubMedGoogle Scholar
  28. 28.
    Lau GK, et al. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology. 2002;122(3):614–24.CrossRefGoogle Scholar
  29. 29.
    Chang C, et al. Expression of the precore region of an avian hepatitis B virus is not required for viral replication. J Virol. 1987;61(10):3322–5.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Milich DR, et al. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A. 1990;87(17):6599–603.CrossRefGoogle Scholar
  31. 31.
    Terazawa S, et al. Hepatitis B virus mutants with precore-region defects in two babies with fulminant hepatitis and their mothers positive for antibody to hepatitis B e antigen. Pediatr Res. 1991;29(1):5–9.CrossRefGoogle Scholar
  32. 32.
    Milich DR. Do T cells “see” the hepatitis B core and e antigens differently? Gastroenterology. 1999;116(3):765–8.CrossRefGoogle Scholar
  33. 33.
    Milich DR, et al. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J Immunol. 1998;160(4):2013–21.PubMedGoogle Scholar
  34. 34.
    Milich DR, et al. Role of T-cell tolerance in the persistence of hepatitis B virus infection. J Immunother Emphasis Tumor Immunol. 1993;14(3):226–33.CrossRefGoogle Scholar
  35. 35.
    Petit MA, Pillot J. HBc and HBe antigenicity and DNA-binding activity of major core protein P22 in hepatitis B virus core particles isolated from the cytoplasm of human liver cells. J Virol. 1985;53(2):543–51.PubMedPubMedCentralGoogle Scholar
  36. 36.
    Zoulim F, Saputelli J, Seeger C. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol. 1994;68(3):2026–30.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Keasler VV, et al. Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol. 2007;81(6):2656–62.CrossRefGoogle Scholar
  38. 38.
    Tang H, et al. Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci. 2006;97(10):977–83.CrossRefGoogle Scholar
  39. 39.
    Muroyama R, et al. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma. J Hepatol. 2006;45(6):805–12.CrossRefGoogle Scholar
  40. 40.
    Benhenda S, et al. Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis. Adv Cancer Res. 2009;103:75–109.CrossRefGoogle Scholar
  41. 41.
    Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol. 2001;36(10):651–60.CrossRefGoogle Scholar
  42. 42.
    Wang Z, Wu Z, Huang P. The function of miRNAs in hepatocarcinogenesis induced by hepatitis B virus X protein (review). Oncol Rep. 2017;38(2):652–64.CrossRefGoogle Scholar
  43. 43.
    Niu C, et al. The Smc5/6 complex restricts HBV when localized to ND10 without inducing an innate immune response and is counteracted by the HBV X protein shortly after infection. PLoS One. 2017;12(1):e0169648.CrossRefGoogle Scholar
  44. 44.
    Zoulim F, Seeger C. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J Virol. 1994;68(1):6–13.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Nassal M. Hepatitis B viruses: reverse transcription a different way. Virus Res. 2008;134(1–2):235–49.CrossRefGoogle Scholar
  46. 46.
    Omata M, Ehata T, Yokosuka O, et al. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med. 1991;324(24):1699–704.CrossRefGoogle Scholar
  47. 47.
    Liang TJ, Hasegawa K, Rimon N, et al. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med. 1991;324(24):1705–9.CrossRefGoogle Scholar
  48. 48.
    Ozasa A, Tanaka Y, Orito E, et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology. 2006;44(2):326–34.CrossRefGoogle Scholar
  49. 49.
    Kusakabe A, Tanaka Y, Mochida S, et al. Case-control study for the identification of virological factors associated with fulminant hepatitis B. Hepatol Res. 2009;39(7):648–56.CrossRefGoogle Scholar
  50. 50.
    Baumert TF, et al. Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest. 1996;98(10):2268–76.CrossRefGoogle Scholar
  51. 51.
    Zoulim F, Locarnini S. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology. 2009;137(5):1593–608.e1–2.CrossRefGoogle Scholar
  52. 52.
    Wai CT, Fontana RJ, Polson J, et al. Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States. J Viral Hepat. 2005;12(2):192–8.CrossRefGoogle Scholar
  53. 53.
    Ren X, Xu Z, Liu Y, et al. Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis. J Viral Hepat. 2010;17(12):887–95.CrossRefGoogle Scholar
  54. 54.
    Xiao L, Zhou B, Gao H, et al. Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute-on-chronic liver failure. J Med Virol. 2011;83(9):1544–50.CrossRefGoogle Scholar
  55. 55.
    Zhu CL, et al. Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B. World J Gastroenterol. 2005;11(44):6936–40.CrossRefGoogle Scholar
  56. 56.
    Han M, et al. Hepatitis B virus-induced hFGL2 transcription is dependent on c-Ets-2 and MAPK signal pathway. J Biol Chem. 2008;283(47):32715–29.CrossRefGoogle Scholar
  57. 57.
    Li W, et al. Antiviral resistance mutations potentiate HBV surface antigen-induced transcription of hfgl2 prothrombinase gene. Biochemistry (Mosc). 2011;76(9):1043–50.CrossRefGoogle Scholar
  58. 58.
    Xia LM, et al. HBx protein induces expression of MIG and increases migration of leukocytes through activation of NF-kappaB. Virology. 2009;385(2):335–42.CrossRefGoogle Scholar
  59. 59.
    Zhou Y, et al. Hepatitis B virus protein X-induced expression of the CXC chemokine IP-10 is mediated through activation of NF-kappaB and increases migration of leukocytes. J Biol Chem. 2010;285(16):12159–68.CrossRefGoogle Scholar
  60. 60.
    Pan X, et al. Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-kappaB. Mol Immunol. 2011;48(12–13):1573–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. and Huazhong University of Science and Technology Press 2019

Authors and Affiliations

  • Hong Tang
    • 1
  • Mei-Fang Han
    • 2
  • Ji-Ming Zhang
    • 3
  1. 1.West China Hospital, Sichuan UniversityChengduChina
  2. 2.Tongji Hospital of Tongji Medical College, Huazhong University of Science and TechnologyWuhanChina
  3. 3.Huashan Hospital, Fudan UniversityShanghaiChina

Personalised recommendations